This provider
- Sponsors financed
- 1
- Repeat sponsors
- 0
- Announced deals
- 1
The capital provider's name, 9 additional sponsor and service provider relationships
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
1 sponsor, 1 observed deal as capital provider, equity provider: (1).
Observed financing in healthcare services (1).
1 sponsor observed, 0 of them more than once.
- this provider financed on its deal for Vivos Therapeutics, Inc. (2026). Roles: capital provider, equity provider. sec.gov
- Provider kinds
- Observed sponsor backerFactsources in which the provider appears· 100%
- Capital side
- EquityFactacted as equity provider in an observed transaction· 85%· DFX's own graph
- Independent sponsor friendliness
- ObservedFact1 observed sponsor transaction· 90%· DFX's own graph
- Mar 31, 2026Minority investmentconfidence 85%this provider · Capital provider
DFX has not observed these firms together on any transaction in our coverage. That is a statement about what DFX has read, not about the firms: a deal that was never announced, or announced without naming its capital, cannot appear here.
Coverage behind this list: 3 sponsors observed closing in your sector · 1 of your own financings read in those sectors · most recent of theirs observed Sep 8, 2026.
- Capital named on their deals: True West Capital Partners
- Capital named on their deals: FS Global Advisor, LLC, Genesis Park, Manolin Investment Group, SharpVue Capital, Tecum Capital
- Capital named on their deals: Kelly Roofing Holdings LLC, Interlang, Inc. d/b/a Montgomery DME, Maranon Capital, Sweet Tooth Enterprises, LLC
| Fact | Value | Class | Effective | Source |
|---|---|---|---|---|
| Entity kind | Unknown investment entity | Inference | 2026-09-28 | DFX model output (scores, estimates, matches) no URL |